NCT00118209

Clinical Trial Information


Trial Number: NCT00118209 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas
Study ID:
CALGB-50303
Images are available?:
Yes
Imaging data can be requested via the NCTN/NCORP Data Archive. To view imaging data details before requesting data here, visit:
The Cancer Imaging Archive (TCIA), NCI's official imaging repository for NCTN trials
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00118209-D2 Dataset NCT00118209-D2-Dataset.csv (adverse_events) is one of 2 datasets (NCT00118209-D1 and NCT00118209-D2) associated with PubMed ID 30939090. This dataset contains information that will allow you to reproduce the safety analysis and toxicity tables during treatment.
NCT00118209-D1 Dataset NCT00118209-D1-Dataset.csv (master) is one of 2 datasets (NCT00118209-D1 and NCT00118209-D2) associated with PubMed ID 30939090. This dataset contains information that will allow you to reproduce the baseline characteristics table, primary and secondary analyses, and the primary cause of death.

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®